RJDG a penny stock with earnings and huge prospects for growth in software services for healthcare.
TLTFF - announced the 90 day results after treatment for bladder cancer with Photo Dynamic Compound actuated by controlled/cell sensitized cold laser. These three patients had failed all other treatments and left with bladder removal/resection as an option. 90 day trial early results indicates no detectable cancer in two patients and one has red spots that will be biopsied. All this from a treatment that has no side affects and could be repeated if necessary. Meanwhile it is important to realize that bladder cancer has an 80% recurrence rate and the US alone is a $4 Billion market. Trading at 35 cents and somewhat over 200 million OS. Next step is 6 patients considered to have exhausted all other options with 6 month follow up and then 26 location trials world wide have been projected.
Read the TLT Canadian news today or Investors Hub repost at TLTFF.